Reply
Charlotte R. Grant, Rodrigo Liberal, Yun Ma, Simon C. Robson, Giorgina Mieli‐Vergani, Diego Vergani, Maria Serena Longhi – 12 July 2014
Elevated serum levels of Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients
Kazumi Yamasaki, Masakuni Tateyama, Seigo Abiru, Atsumasa Komori, Shinya Nagaoka, Akira Saeki, Satoru Hashimoto, Ryu Sasaki, Shigemune Bekki, Yuki Kugiyama, Yuri Miyazoe, Atsushi Kuno, Masaaki Korenaga, Akira Togayachi, Makoto Ocho, Masashi Mizokami, Hisashi Narimatsu, Hiroshi Yatsuhashi – 12 July 2014 – The Wisteria floribunda agglutinin‐positive human Mac‐2‐binding protein (WFA+‐M2BP) was recently shown to be a liver fibrosis glycobiomarker with a unique fibrosis‐related glycoalteration.
Ongoing activation of autoantigen‐specific B cells in primary biliary cirrhosis
Jun Zhang, Weici Zhang, Patrick S.C. Leung, Christopher L. Bowlus, Sandeep Dhaliwal, Ross L. Coppel, Aftab A. Ansari, Guo‐Xiang Yang, Jinjun Wang, Thomas P. Kenny, Xiao‐Song He, Ian R. Mackay, M. Eric Gershwin – 12 July 2014
Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network
Victor J. Navarro, Huiman Barnhart, Herbert L. Bonkovsky, Timothy Davern, Robert J. Fontana, Lafaine Grant, K. Rajender Reddy, Leonard B. Seeff, Jose Serrano, Averell H. Sherker, Andrew Stolz, Jayant Talwalkar, Maricruz Vega, Raj Vuppalanchi – 12 July 2014 – The Drug‐Induced Liver Injury Network (DILIN) studies hepatotoxicity caused by conventional medications as well as herbals and dietary supplements (HDS).
Reply
Konstantin Kazankov, Holger Jon Møller, Bo Martin Bibby, Hendrik Vilstrup, Jacob George, Henning Grønbæk – 12 July 2014
Reply
Kaoru Tsuchiya, Yasuhiro Asahina, Masayuki Kurosaki, Nobuyuki Enomoto, Namiki Izumi – 11 July 2014
Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012
Richard S. Hoehn, Gregory C. Wilson, Koffi Wima, Samuel F. Hohmann, Emily F. Midura, E. Steve Woodle, Daniel E. Abbott, Ashish Singhal, Shimul A. Shah – 11 July 2014 – A complete evaluation of living donor liver transplantation (LDLT) in the United States has been difficult because of the persistent low volume and the lack of adequate comparisons with deceased donor liver transplantation (DDLT). Recent reports have suggested outcomes equivalent to those for DDLT, but these studies did not adjust for differences in recipient selection.
Is there an ideal cutoff for α‐fetoprotein as an exclusion criterion for liver transplantation?
Angelo Alves Mattos, Luciana Santos Schraiber, Maria Lucia Zanotell, Guido Cantisani – 11 July 2014
Reframing the impact of combined heart‐liver allocation on liver transplant wait‐list candidates
David S. Goldberg, Peter P. Reese, Sandra Amaral, Peter L. Abt – 11 July 2014 – Simultaneous heart‐liver (H‐L) transplantation, although rare, has become more common in the United States. When the primary organ is a heart or liver, patients receiving an offer for the primary organ automatically receive the second, nonprimary organ from that donor. This policy raises issues of equity, such as whether liver transplantation alone candidates bypassed by H‐L recipients are disadvantaged.
To whom goes the kidney?
Jayme E. Locke – 11 July 2014